Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic Equivalence of Two Orlistat Dosage Forms
2007-004797-79Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of orlistat in obesity (2 arms), sponsored by GSK. Primary endpoint: Faecal fat content. Started Oct 2007; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on 2007-004797-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004797-79.